CLOV - CIK 0001801170
The table below shows CLOVER HEALTH INVESTMENTS, CORP. /DE's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$66.93M | $34.84M | -$144.66M | -$203.93M | -$282.33M | -$118.50M |
| Capital expenditure | $2.04M | $1.56M | $584.00K | $4.47M | $723.00K | $693.00K |
| Investing cash flow | $4.08M | $565.00K | $140.01M | $95.13M | -$435.45M | $137.40M |
| Dividends paid | - | - | - | - | - |
CLOVER HEALTH INVESTMENTS, CORP. /DE reported operating cash flow of -$66.93M for fiscal year 2025. That is down 292.1% from $34.84M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from -$159.88M (FY 2019) to -$66.93M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $18.30M | $1.77M | $0.00 | $0.00 | $147.00K | $0.00 |
| Financing cash flow | -$53.38M | -$17.36M | -$5.07M | -$4.96M | $925.39M | $5.84M |